非肾小球性慢性肾脏病儿童和青少年中贫血与身高生长障碍的纵向关系:来自CKiD研究的结果
CKiD多中心前瞻性队列研究纳入510例未达最终成年身高的非肾小球性CKD患者(<22岁),共1763人次访视。随访期间67%的患者血红蛋白z评分呈下降轨迹;与平均血红蛋白z评分≥0相比,平均血红蛋白z评分<-1.0与随后访视时身高z评分下降0.24至0.35相关,且50%的病例其血红蛋白z评分<-1.0对应的血红蛋白值高于KDIGO指南定义贫血的切点。
要点
- 随访期间67%的非肾小球性CKD患儿血红蛋白z评分呈下降轨迹。
- 平均血红蛋白z评分<-1.0与随后访视身高z评分下降0.24至0.35独立相关。
- 50%的血红蛋白z评分<-1.0病例其血红蛋白值高于KDIGO贫血切点。
核心结论
- 在轻至中度非肾小球性CKD儿童中,血红蛋白下降随时间与生长障碍相关,甚至发生在血红蛋白水平达到目前用于定义贫血的切点之前。
研究设计与样本
- CKiD研究为多中心前瞻性队列研究,随访观察超过15年。
- 纳入510例年龄小于22岁、未达最终成年身高的非肾小球性CKD患者,共1763人次访视。
- 暴露为年龄、性别和种族特异性血红蛋白z评分;结局为年龄和性别特异性身高z评分。
- 采用多变量重复测量配对访视分析和多变量重复测量线性混合模型分析,均校正年龄、性别、体重指数、估算肾小球滤过率、酸中毒和药物使用。
主要发现
- 510例参与者中67%在随访期间血红蛋白z评分呈下降轨迹,共1763人次访视。
- 与平均血红蛋白z评分≥0相比,平均血红蛋白z评分<-1.0与随后研究访视时显著生长障碍独立相关,身高z评分下降范围为0.24至0.35。
- 50%的血红蛋白z评分<-1.0病例对应的血红蛋白值高于KDIGO慢性肾脏病贫血临床实践指南中定义贫血的切点。
- 按年龄分层,关联幅度在9岁参与者中达到峰值。
- 混合模型分析显示,基线血红蛋白z评分<-1.0的参与者中,随访期间血红蛋白z评分下降与身高z评分同期统计学显著下降相关。
关键数值与推荐
- 平均血红蛋白z评分<-1.0与随后身高z评分下降0.24至0.35相关(参照组为平均血红蛋白z评分≥0)。
- 50%的血红蛋白z评分<-1.0病例其血红蛋白值高于KDIGO指南定义贫血的切点。
局限性
- 推断因果关系的能力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Anemia and statural growth impairment are both prevalent in children with nonglomerular chronic kidney disease (CKD) and are associated with poor quality of life and increased morbidity and mortality. However, to date no longitudinal studies have demonstrated a relationship between anemia and statural growth in this population. STUDY DESIGN: The CKD in Children (CKiD) study is a multicenter prospective cohort study with over 15 years of follow-up observation. SETTING & PARTICIPANTS: CKiD participants younger than 22 years with nonglomerular CKD who had not reached final adult height. EXPOSURE: Age-, sex-, and race-specific hemoglobin z score. OUTCOME: Age- and sex-specific height z score. ANALYTICAL APPROACH: The relationship between hemoglobin and height was quantified using (1) multivariable repeated measures paired person-visit analysis, and (2) multivariable repeated measures linear mixed model analysis. Both models were adjusted for age, sex, body mass index, estimated glomerular filtration rate, acidosis, and medication use. RESULTS: Overall, 67% of the 510 participants studied had declining hemoglobin z score trajectories over the follow-up period, which included 1,763 person-visits. Compared with average hemoglobin z scores of≥0, average hemoglobin z scores of less than -1.0 were independently associated with significant growth impairment at the subsequent study visit, with height z score decline ranging from 0.24 to 0.35. Importantly, in 50% of cases hemoglobin z scores of less than -1.0 corresponded to hemoglobin values higher than those used as cutoffs defining anemia in the KDIGO clinical practice guideline for anemia in CKD. When stratified by age, the magnitude of the association peaked in participants aged 9 years. In line with paired-visit analyses, our mixed model analysis demonstrated that in participants with baseline hemoglobin z score less than -1.0, a hemoglobin z score decline over the follow-up period was associated with a statistically significant concurrent decrease in height z score. LIMITATIONS: Limited ability to infer causality. CONCLUSIONS: Hemoglobin decline is associated with growth impairment over time in children with mild to moderate nonglomerular CKD, even before hemoglobin levels reach the cutoffs that are currently used to define anemia in this population.
引用
- Akchurin O, Molino AR, Schneider MF, et al. Longitudinal Relationship Between Anemia and Statural Growth Impairment in Children and Adolescents With Nonglomerular CKD: Findings From the Chronic Kidney Disease in Children (CKiD) Study. Am J Kidney Dis. 2022. PMID: 36481700. doi:10.1053/j.ajkd.2022.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。